These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 328198)

  • 1. Specific removal of DNA antibodies in vivo by extracorporeal circulation over DNA immunobilized in collodion charcoal.
    Terman DS; Petty D; Harbeck R; Carr RI; Buffaloe G
    Clin Immunol Immunopathol; 1977 Jul; 8(1):90-6. PubMed ID: 328198
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific removal of antibody by extracorporeal circulation over antigen immobilized in collodion-charcoal.
    Terman DS; Tavel T; Petty D; Racic MR; Buffaloe G
    Clin Exp Immunol; 1977 Apr; 28(1):180-8. PubMed ID: 862246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal removal of anti-DNA antibodies in systemic lupus erythematosus using DNA-collagen films.
    Laville M; el Habib R; Traeger J; Coulet PR; Gautheron DC; Sanhadji K; My H; Zech PY
    Life Support Syst; 1983; 1 Suppl 1():65-70. PubMed ID: 6400735
    [No Abstract]   [Full Text] [Related]  

  • 4. Specific adsorption of circulating antibodies by extracorporeal plasma perfusions over antigen coated collagen flat-membranes: applications to systemic lupus erythematosus.
    El-Habib R; Laville M; Traeger J
    J Clin Lab Immunol; 1984 Nov; 15(3):111-7. PubMed ID: 6397594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific extraction of antigen in vivo by extracorporeal circulation over antibody immobilized in collodion-charcoal.
    Terman DS; Petty D; Ogden D; Pefley C; Buffaloe G
    J Immunol; 1976 Nov; 117(5 Pt.2):1971-5. PubMed ID: 62800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New method for the specific clearance of antibodies using antigens linked to a collagen film.
    El Habib R; Traeger J; Gautheron DC; Coulet PR
    Biomed Pharmacother; 1982; 36(6-7):302-7. PubMed ID: 6763880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal immunoadsorption: initial experience in human systemic lupus erythematosus.
    Terman DS; Buffaloe G; Mattioli C; Cook G; Tillquist R; Sullivan M; Ayus JC
    Lancet; 1979 Oct; 2(8147):824-7. PubMed ID: 90920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific removal of DNA antibodies in vivo with an extracorporeal immuno-adsorbent.
    Terman DS; Stewart I; Robinette J; Carr R; Harbeck R
    Clin Exp Immunol; 1976 May; 24(2):231-7. PubMed ID: 1277577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of systemic lupus erythematosus by extracorporeal immunoadsorption.
    Palmer A; Gjorstrup P; Severn A; Welsh K; Taube D
    Lancet; 1988 Jul; 2(8605):272. PubMed ID: 2899250
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effectiveness of specific removal of anti-DNA antibodies in vivo--an application of anti-DNA antibody immunoadsorption in NZBxNZW F1 hybrid mice].
    Kiyohara A
    Nihon Hifuka Gakkai Zasshi; 1988 Jun; 98(7):689-95. PubMed ID: 3074188
    [No Abstract]   [Full Text] [Related]  

  • 11. Extracorporeal modification of plasma and whole blood.
    Saal SD; Gordon BR
    Prog Clin Biol Res; 1982; 106():375-84. PubMed ID: 6757951
    [No Abstract]   [Full Text] [Related]  

  • 12. Attenuation of canine nephrotoxic glomerulonephritis with an extracorporeal immunoadsorbent.
    Terman DS; Durante D; Buffaloe G; McIntosh R
    Scand J Immunol; 1977; 6(3):195-202. PubMed ID: 847401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for selective removal of plasma constituents.
    Pineda AA
    Prog Clin Biol Res; 1982; 106():361-73. PubMed ID: 6757950
    [No Abstract]   [Full Text] [Related]  

  • 14. Extracorporeal removal of specific antibodies by hemoperfusion through the immunosorbent agarose-polyacrolein microsphere beads: removal of anti-bovine serum albumin in animals.
    Marcus L; Mashiah A; Offarim M; Margel S
    J Biomed Mater Res; 1984; 18(9):1153-67. PubMed ID: 6400018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoadsorption (IAS) for systemic lupus erythematosus.
    Stummvoll GH
    Lupus; 2011 Feb; 20(2):115-9. PubMed ID: 21303827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous removal of anti-DNA antibody, using a new extracorporeal immunoadsorption system, in patients with systemic lupus erythematosus.
    Suzuki K; Hara M; Harigai M; Ishizuka T; Hirose T; Matsuki Y; Kawaguchi Y; Kitani A; Kawagoe M; Nakamura H
    Arthritis Rheum; 1991 Dec; 34(12):1546-52. PubMed ID: 1747139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Obtaining pure antibodies with the aid of an immunosorbent based on sephadex].
    Shekhonin BV; Rukosuev VS; Fedorova EN
    Arkh Patol; 1979; 41(6):55-7. PubMed ID: 88932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-affinity anti-DNA antibody parallels clinical course of immunoadsorption therapy for systemic lupus erythematosus.
    Funauchi M; Ikoma S; Enomoto H; Ohno M; Kinoshita K; Horiuchi A; Kurata N
    Intern Med; 1996 May; 35(5):367-72. PubMed ID: 8797048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal immunoadsorption therapy on rats. In vivo depletion of specific antibodies.
    Nilsson R; Lindgren L; Lilliehorn P
    Clin Exp Immunol; 1990 Dec; 82(3):440-4. PubMed ID: 2265485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of immunoadsorption on the removal of immunoglobulin G autoantibodies in crescentic glomerulonephritis.
    Esnault VL; Testa A; Jayne DR; Soulillou JP; Guenel J
    Nephron; 1993; 65(2):180-4. PubMed ID: 8247177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.